Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.
Dr Louise Clarke discusses presentations of viral vulvo-vaginal infections and how nurses can ensure prompt diagnosis and appropriate care ...
Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, ...
Long-term valacyclovir does not significantly reduce stromal keratitis risk in patients with herpes zoster ophthalmicus, a study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results